Group 1 - The core viewpoint of the report is that 招银国际 maintains a "Buy" rating for 华润万象生活 (01209) and raises the target price by 4% to HKD 53.96 [1] - 招银国际 forecasts that 华润万象生活's revenue will reach RMB 18.2 billion in 2025, representing a year-on-year growth of 6.5%, with residential business revenue remaining flat due to the drag from value-added services, while commercial operations revenue is expected to grow by 13.8% [1] - The forecast for 华润万象生活's core net profit in 2025 is projected to increase by 10.8% to RMB 3.9 billion, supported by stable gross margins in property management, improving gross margins in shopping centers, and a decrease in the ratio of selling and administrative expenses [1] Group 2 - 招银国际 maintains its revenue forecasts for 2025 to 2027 unchanged, but has adjusted the core net profit forecast down by 4% due to a more reasonable pace of margin expansion [1]

Core Insights - Medtronic (MDT.US) shares rose 4% in pre-market trading, reaching $100.14 [1] - For Q2 of fiscal year 2026, Medtronic reported a non-GAAP EPS of $1.36, up from $1.26 a year ago, exceeding analyst expectations of $1.31 [1] - The quarterly net sales for the period ending October 24 were $8.96 billion, compared to $8.4 billion in the same quarter last year, surpassing the expected $8.87 billion [1] - Medtronic raised its fiscal year 2026 non-GAAP EPS guidance to a range of $5.62 to $5.66, up from the previous guidance of $5.60 to $5.66, aligning with analyst expectations of $5.62 [1] - The new earnings guidance includes an estimated impact of approximately $185 million from potential tariffs [1] - The revenue growth forecast for fiscal year 2026 was increased from 5% to 5.5% [1]